An Optimized Protocol for Simultaneous Propagation of Patient-derived Organoids and Matching CAFs
Recurrent hormone receptor-positive (HR+) breast cancer is a leading cause of cancer mortality in women. Recurrence and resistance to targeted therapies have been difficult to study due to the long clinical course of the disease, the complex nature of resistance, and the lack of clinically relevant...
Saved in:
Main Authors: | Jenny Högström, Taru Muranen |
---|---|
Format: | Article |
Language: | English |
Published: |
Bio-protocol LLC
2025-01-01
|
Series: | Bio-Protocol |
Online Access: | https://bio-protocol.org/en/bpdetail?id=5160&type=0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-reduction strategy to culture patient derived bladder tumor organoids
by: Mahsa Mollapour Sisakht, et al.
Published: (2025-02-01) -
Protocol for functional screening of CFTR-targeted genetic therapies in patient-derived organoids using DETECTOR deep-learning-based analysis
by: Mattijs Bulcaen, et al.
Published: (2025-03-01) -
Gene Editing in Pluripotent Stem Cells and Their Derived Organoids
by: Hang Zhou, et al.
Published: (2021-01-01) -
Protocol for engineering bone organoids from mesenchymal stem cells
by: Jian Wang, et al.
Published: (2025-03-01) -
Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4+ and CD8+ T cells
by: Feilong Ren, et al.
Published: (2025-01-01)